*001920144
*00520250613174227.0
*007ta
*008020424s2000    xxu           000 u eng d
*00900721cam a22002057c 4500
*019  $bl
*035  $a(EXLNZ-47BIBSYS_NETWORK)990210086984702201
*035  $a(NO-LaBS)15131371(bibid)
*035  $a(NO-TrBIB)021008698
*035  $a021008698-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*24500$aCreating markets for new vaccines :$bpart I : rationale$cMichael Kremer
*260  $aCambridge, Mass.$bNBER$c2000
*300  $a49 s.
*4901 $aNBER working paper series$v7716
*7001 $aKremer, Michael$_38935400
*7102 $aNational Bureau of Economic Research (Forente Stater)$_13074800
*830 0$aWorking paper series (National Bureau of Economic Research : trykt utg.)$x0898-2937$v7716$w999105437124702201$_13074900
*901  $a60
*999  $aoai:nb.bibsys.no:990210086984702202$b2021-11-14T20:59:51Z$z990210086984702202
^